Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Salestools Logo

Salestools

#1 AI-agent för säljteam och Go-to-Market-team. Sälj mer, snabbare, med mindre ansträngning.

Produkt

  • AI-säljagenter
  • Intentionsdata
  • Teknologidata
  • Besöksspårning
  • Medpilot
  • Social Försäljning

Lösningar

  • Kundservice
  • E-handel
  • SaaS
  • Företag
  • Småföretag

Resurser

  • Rapporten
  • Dokumentation
  • API-referens
  • Hjälpcenter
  • Blogg
  • Fallstudier
  • Webbinarier

Företag

  • Om oss
  • Karriärer
  • Press
  • Kontakt
  • Partners

Våra kontor

  • New York, HQ
  • Bukarest, AI-forskningslabb
  • Zug, Schweiz

© 2025 Salestools. Alla rättigheter förbehållna.

Datavillkor och SäkerhetSekretesspolicyAnvändarvillkor
Alla system fungerar
Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Back to The Report
Fundraising

Isomorphic Labs

Isomorphic Labs Raises $600M in Series B

2021
Founded
150+
Employees
London, UK
Updated March 12, 2025
2 min read

Quick Facts

Isomorphic Labs Raises $600M in Series B


Isomorphic Labs has successfully raised $600M in a Series B at a $3.5B valuation led by Alphabet, Andreessen Horowitz.


Company Overview


Isomorphic Labs is a Biotech company headquartered in London, UK, founded in 2021 with 150+ employees.


AI-powered drug discovery platform applying machine learning to molecular design


Fundraising Details


  • Amount Raised: $600M
  • Round Type: Series B
  • Valuation: $3.5B
  • Date: 2025-03-12
  • Investors: Alphabet, Andreessen Horowitz

About Isomorphic Labs


AI-powered drug discovery platform applying machine learning to molecular design The company is positioned in the Biotech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: London, UK
  • Founded: 2021
  • Team Size: 150+
  • Industry: Biotech

What This Means


This funding round demonstrates strong investor confidence in Isomorphic Labs's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Isomorphic Labs's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $3.5B valuation marks an important milestone for Isomorphic Labs, positioning the company among notable players in the Biotech industry.


Looking Ahead


With this new capital, Isomorphic Labs is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-03-12. For more information about Isomorphic Labs, visit their headquarters at London, UK.

Topics

Fundraising(2912)Series B(293)BiotechIsomorphic Labs

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million